SPECIAL EMPHASIS PANELS


To view other meetings from ZAG1 choose calendar year:

Study Section Panel Name Meeting Rosters
ZAG1 ZIJ-P(O3) COGNITIVE IMPAIRMENT AND AD PREDICTION - II. 05/08/24
ZAG1 ZIJ-8(M4) CONSORTIUM FOR ECONOMIC RESEARCH ON AD_ADRD RESEARCH 04/02/24
ZAG1 ZIJ-6(M2) BIOMARKERS OF COGNITIVE DECLINE 03/27/24
ZAG1 ZIJ-S(M4) STATE DEMENTIA CARE RESEARCH CENTER 03/25/24
ZAG1 ZIJ-8(M2) DOMINANTLY INHERITED ALZHEIMER NETWORK 03/22/24
ZAG1 ZIJ-G(M2) CLINICAL TRIALS REVIEW 03/21/24
ZAG1 ZIJ-A(M4) ALZHEIMER’S DISEASE AND PROTEOLYTIC AND METABOLIC DYSFUNCTION 03/20/24
ZAG1 ZIJ-3(M3) INTERDISCIPLINARY AGING INFRASTRUCTURE 03/20/24
ZAG1 ZIJ-3(M4) INTERDISCIPLINARY AGING INFRASTRUCTURE 03/20/24
ZAG1 ZIJ-7(M1) AGING HORMONE STUDY 03/19/24
ZAG1 ZIJ-G(M3) AD/ADRD MANAGEMENT EVOLUTION 03/19/24
ZAG1 ZIJ-5(M5) HEALTHCARE DECISION MAKING 03/18/24
ZAG1 ZIJ-P(C1) SBIR CONTRACT TOPIC 010 03/15/24
ZAG1 ZIJ-I(M1) REDI SMALL BUSINESS REVIEW PANEL 03/15/24
ZAG1 ZIJ-A(M2) BIOMARKERS VALIDATION FOR ALZHEIMER’S DISEASE AND RELATED DEMENTIA 03/13/24
ZAG1 ZIJ-D(M2) AGING TRENDS AND CAREGIVING 03/12/24
ZAG1 ZIJ-I(M2) REDI R25 REVIEW PANEL 03/08/24
ZAG1 ZIJ-6(M1) K76 BEESON REVIEW 03/07/24
ZAG1 ZIJ-9(M1) BEHAVIORAL AND SOCIAL RESEARCH ON IMMIGRATION AND AGING 03/07/24
ZAG1 ZIJ-A(M3) ROLE OF TAU OLIGOMER POLYMORPHISM IN ALZHEIMER’S DISEASE AND RELATED DISORDERS 03/06/24
ZAG1 ZIJ-J(M2) PK/PD OF MTOR INHIBITORS IN AGING 03/05/24
ZAG1 ZIJ-9(M4) HEALTH EQUITY AND COST AD/ADRD 03/05/24
ZAG1 ZIJ-I(M3) R01 REVIEW PANEL ON CLONAL HEMATOPOIESIS 03/04/24
ZAG1 ZIJ-5(M2) NURSING HOME CLINICAL TRIALS NETWORK 03/04/24
ZAG1 ZIJ-G(M1) GAIT AS DEVELOPMENTAL AD MARKER 03/01/24
ZAG1 ZIJ-9(M2) BEHAVIORAL AND SOCIAL RESEARCH NETWORKS 02/29/24
ZAG1 ZIJ-S(M3) AD/ADRD RESEARCH - RENEWAL AND COMPETING REVISION COOPERATIVE AGREEMENTS 02/29/24
ZAG1 ZIJ-3(M5) FETAL PROGRAMMING AND AGING 02/27/24
ZAG1 ZIJ-9(M3) SOCIAL AND BEHAVIORAL DETERMINANTS OF HEALTH IN AD/ADRD AND DISPARITIES 02/27/24
ZAG1 ZIJ-5(M1) MEASURING FINANCIAL HARDSHIP WITH AD/ADRD 02/23/24
ZAG1 ZIJ-R(M1) GEMSSTAR 02/22/24
ZAG1 ZIJ-J(M4) ALZHEIMER’S DISEASE SEQUENCING PROJECT 02/22/24
ZAG1 ZIJ-8(M3) ADVANCING MOBILE MONITORING OF INTRAINDIVIDUAL CHANGE IN ADRD 02/22/24
ZAG1 ZIJ-2(M2) BRAIN AGING MODELS 02/21/24
ZAG1 ZIJ-A(M1) EXERCISE TRAINING IN OLDER ADULTS AND THE PHYSIOLOGIC AND FUNCTIONAL RESPONSES 02/21/24
ZAG1 ZIJ-3(M2) PRIMATE AGING NETWORKING AND INFRASTRUCTURE 02/21/24
ZAG1 ZIJ-R(M3) ASPREE-XT RENEWAL REVIEW 02/15/24
ZAG1 ZIJ-D(M3) SEX DIFFERENCES IN AD 02/15/24
ZAG1 ZIJ-P(M1) GENE-ENVIRONMENTAL INTERACTIONS ON AGING AND AD-RELATED DEMENTIAS 02/14/24
ZAG1 ZIJ-P(M3) IMPACT OF TOXICANTS ON AGING AND AD-RELATED DEMENTIAS 02/14/24
ZAG1 ZIJ-P(M2) ENVIRONMENTAL FACTORS ON AGING AND AD-RELATED DEMENTIAS 02/13/24
ZAG1 ZIJ-S(M5) BRAIN CELL ATLAS OF AD/ADRD 02/12/24
ZAG1 ZIJ-G(M4) MEMBER CONFLICT SEP FOR MID-CAREER AWARDS/CLINICAL CANDIDATES 02/12/24
ZAG1 ZIJ-J(M1) TRANSITION TO AGING RESEARCH AWARD FOR PREDOCTORAL STUDENTS 02/08/24
ZAG1 ZIJ-2(M1) NAD CT 02/07/24
ZAG1 ZIJ-R(M2) FUTURE ADRD PREVENTION WITH INTENSIVE TREATMENT OF HYPERTENSION 02/02/24
ZAG1 ZIJ-3(M1) COMPARATIVE PRIMATE AGING AND LONGEVITY 01/30/24
ZAG1 ZIJ-1(M1) TREAT-AD 01/29/24
ZAG1 ZIJ-I(M4) ALPHA HERPES VIRUSES AND ALZHEIMER'S DISEASE PROGRESSION 01/26/24
ZAG1 ZIJ-D(M1) ELDER ABUSE & ADRD 01/25/24
ZAG1 ZIJ-S(M1) DEMENTIA CAREGIVER SUPPORT INTERVENTION 01/22/24
ZAG1 ZIJ-S(M2) SANGHI 3-25-2024 01/22/24
ZAG1 ZIJ-8(M1) MECHANISMS UNDERLYING HETEROGENEITY OF COGNITIVE OUTCOMES IN SYNUCLEINOPATHY 01/22/24
ZAG1 ZIJ-1(C3) MECHANISM-BASED ADULT STEM CELL TREATMENTS FOR AGING PATHOLOGIES 01/19/24
ZAG1 ZIJ-J(M3) ALZHEIMER’S DISEASE DRUG DEVELOPMENT 01/18/24
ZAG1 ZIJ-1(C1) GENE DELIVERY SYSTEMS FOR AD/ADRD THERAPY DEVELOPMENT 01/16/24
ZAG1 ZIJ-P(M4) GENE-ENVIRONMENT INTERPLAY II 01/09/24